TEAM

Graduated from the Faculty of Medicine, the University of Tokyo, and earned a PhD in medicine at its graduate school.

Has built extensive experience at medical institutions in Japan and abroad.

Specializes in oral surgery and plastic surgery.

Former Professor of Oral and Maxillofacial Surgery, Department of Sensory and Motor System Medicine, Graduate School of Medicine, the University of Tokyo.

Former Director of the Tissue Engineering Department at the University of Tokyo Hospital (concurrent post).

Former Director of the 22nd Century Medical Center at the University of Tokyo Hospital (concurrent post).

Currently Director of JR Tokyo General Hospital.

Head of Oral Surgery and Plastic Surgery.

Board member of the Japanese Society for Regenerative Medicine.

Brought clinical experience and techniques from Canada and the United States to Japan, and has developed many new surgical procedures of his own.

Has worked for many years as a specialist in plastic and aesthetic surgery.

In recent years he has focused on research in regenerative medicine and its clinical application, earning high regard in Japan and abroad.

Served as Vice President of the Japanese Society for Regenerative Medicine.

Recipient of the Japanese Society for Regenerative Medicine Award for Distinguished Achievement.

Graduated from the Faculty of Medicine, Chiba University, then trained at Tokyo Metropolitan Otsuka Hospital and the Department of Plastic Surgery, Tokyo Medical University.

He went on to serve as Director of Will AGA Clinic and as Chairman of the Bojunkai Medical Corporation.

He draws on his background in plastic surgery in his practice at BiOSTYLE CLINIC OSAKA.

After the Department of Thoracic Surgery at Keio University (clinical work and research into cryoablation for lung cancer) and a post as Deputy Head of Thoracic Surgery at Kawasaki Hospital, he moved from general practice into pre-emptive medicine.

Drawing on wide experience in both clinical work and research, he conceived and opened a state-of-the-art clinic dedicated to well-aging through pre-emptive medicine, and became its Director General.

Graduate of the University of Tokyo, MD, PhD.

He has served as Chair of the Department of Diabetes, Metabolism, Endocrinology, Rheumatology and Collagen Diseases at Tokyo Medical University, Deputy Director of its hospital, Head of Endocrinology and Metabolism at Toranomon Hospital, and Clinical Lecturer at the University of Oxford Medical School. He is currently Visiting Professor at Tokyo Medical University.

Specializing in diabetology, endocrinology and metabolism, atherosclerosis and molecular biology, he has led work for many years on the clinical management of atherosclerotic complications and on genetic research into the causes of diabetes and the onset of its complications.

In 1989 he published work on insulin receptor gene abnormalities in Science, and he continues to work on identifying diabetes-related genes, including mitochondrial gene abnormalities.

After graduating from the Nihon University School of Medicine and earning his doctorate (Mh.D), he became Head of the Gastrointestinal Surgery outpatient clinic at Nihon University School of Medicine and Head of Surgery at Tsudanuma Central General Hospital.

He went on to work as a clinician in dendritic cell cancer therapy at a cancer immunotherapy clinic in Tokyo and as director of a members-only health screening facility, and now works on treatment incorporating cancer immunotherapy and on preventing recurrence.

A thoracic surgeon, and the originator and leading authority on photodynamic therapy (PDT) for early-stage lung cancer.

He has served as President of the International Association for the Study of Lung Cancer, and has also held posts including Chairman of the International Society for Laser Medicine and board member of the Japan Surgical Society and the Japan Lung Cancer Society.

Graduated from the Akita University School of Medicine.

Originator of the DWIBS method.

Achieved the world's first imaging of peripheral nerves, published in the New England Journal of Medicine.

He runs headache clinics at the Neuroscience Center of Tokyo Women's Medical University and the Department of Neurology at Dokkyo Medical University Hospital, as well as at Shiodome City Center Central Clinic and elsewhere.

He has published widely, including "Headaches Disappear" (Diamond Inc.).

Professor Emeritus, Tokyo University of Science.

He has a world-leading track record in diagnostic and therapeutic antibodies.

After working at the Kishimoto Institute of Medical Science, Tokiwa Hospital of the Tokiwakai Medical Corporation (Immunology Department, cell culture laboratory) and the Japan Culture Institute,
he now serves concurrently as Head of Culture Technology at SCC Lab Co., Ltd. and Chief Cell Culture Technologist at BiOSTYLE CLINIC OSAKA.

I have been working as a cell culture technologist for about 13 years.

He has worked on research into stem cell culture supernatant, drawing on his knowledge of cell culture to refine his technique.

He is currently researching new stem cell culture supernatants that can perform better, using cells from cord blood, amniotic membrane, placenta and bone marrow.